|3RD GULF NUCLEAR MEDICINE CONFERENCE
|Year : 2013 | Volume
| Issue : 1 | Page : 82-86
Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity
RK Marwaha1, MK Garg2, N Tandon3, Ratnesh Kanwar1, A Narang1, A Sastry1, A Saberwal1, Kuntal Bhadra1
1 Department of Endocrinology & Thyroid Research Centre, Institute of Nuclear Medicine & Allied Sciences (DRDO), Delhi, India
2 Department of Endocrinology & Metabolism, Army Hospital (Research & Referral), Delhi Cantt, New Delhi, India
3 Department of Endocrinology & Metabolism, All India Institute of Medical Sciences, New Delhi, India
|Date of Submission||17-May-2011|
|Date of Web Publication||8-Mar-2013|
R K Marwaha
Department of Endocrinology & Thyroid Research Centre, Institute of Nuclear Medicine & Allied Sciences, Timarpur, Delhi 110 054
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background & objectives: Several autoimmune disorders have been reported to be associated with autoimmune thyroiditis and may coexist with other organ-specific autoantibodies. The aim of the present study was to evaluate the presence of tissue transglutaminase (anti-TTG) and glutamic acid decarboxylase (anti-GAD) antibodies in patients suffering from autoimmune thyroiditis as diagnosed by anti-thyroid peroxidase (anti-TPO) antibodies, which may indicate high risk for developing celiac disease or type 1 diabetes mellitus.
Methods: Five thousand children and 2800 adults were screening as part of a general health examination done on a voluntary basis in four different parts of Delhi. A total of 577 subjects positive for anti-TPO antibody constituted the cases. Equal number of age and sex matched anti-TPO antibody negative controls were randomly selected from the same cohort to form paired case control study. The cases and controls were further divided into two groups as follows: group-1 (children and adolescent <18 yr), group-2 (adults >18 yr). Serum samples of cases and controls were analysed for thyroid function test (FT3, FT4, and TSH), anti-TTG and anti-GAD antibodies.
Results: A total of 1154 subjects (577 cases and 577 controls) were included in this study. Hypothyroidism was present in 40.2 per cent (232) cases compared to only 4.7 per cent (27) in controls (P<0.001). Anti-TTG and anti-GAD antibodies were present in 6.9 and 12.5 per cent subjects among cases compared to 3.5 per cent (P=0.015) and 4.3 per cent (P=0.001) in controls, respectively. Only anti-GAD antibody were significantly positive in cases among children and adolescents (P =0.0044) and adult (P=0.001) compared to controls. Levels of anti-TTG and anti-GAD antibodies increased with increasing titre of anti-TPO antibody.
Interpretation & conclusions: Our findings showed high positivity of anti-GAD and anti-TTG antibodies among subjects with thyroid autoimmunity. It is, therefore, important to have high clinical index of suspicion for celiac disease or type 1 diabetes mellitus in patients with autoimmune thyroiditis.
Keywords: Anti-GAD antibody - anti-TPO antibody - anti-TTG antibody - thyroid autoimmunity
|How to cite this article:|
Marwaha R K, Garg M K, Tandon N, Kanwar R, Narang A, Sastry A, Saberwal A, Bhadra K. Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity. Indian J Med Res 2013;137:82-6
|How to cite this URL:|
Marwaha R K, Garg M K, Tandon N, Kanwar R, Narang A, Sastry A, Saberwal A, Bhadra K. Glutamic acid decarboxylase (anti-GAD) & tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity. Indian J Med Res [serial online] 2013 [cited 2020 Feb 25];137:82-6. Available from: http://www.ijmr.org.in/text.asp?2013/137/1/82/108274
Tolerance to self antigen is acquired by elimination of autoreactive T-cells  and breakdown of this tolerance leads to activation of these cells and consequent autoimmunity. Various mechanisms postulated are genetic susceptibility, release of sequestrated self antigen by infection or molecular mimicry  . This loss of immune tolerance leading to exposure of various tissue specific peptides, results in the development of autoimmune disorders. Presence of auto-antibodies, have a strong predictive value in cases with organ-specific autoimmune disorders, which are known to have a long preclinical phase  . Among patients with type 1 diabetes mellitus (T1DM), evidence based recommendations exist for evaluation of thyroid and gut autoimmunity  . However, no such recommendations exist for patients with autoimmune thyroiditis, which is a common disorder , . In view of limited reports showing association between thyroid autoimmunity, T1DM and celiac disease, especially in children and adolescents ,,,,,, , we undertook this study to evaluate presence of tissue transglutaminase (TTG) and glutamic acid decarboxylase (GAD) antibodies among patients with thyroid autoimmunity.
| Material & Methods|| |
The present study was carried out as part of school health examination and general health check-up on voluntary basis for members of Resident Welfare Associations from four different regions (South, North, West and East) of Delhi between January 2009 - December 2010. A total of 5000 children and 2800 adults were evaluated for detailed clinical and biochemical evaluation. Exclusion criteria included subjects with known systemic disorders or medications. Children (n=236) and adults (n=341) who were found to be positive for anti-thyroid peroxidase (anti-TPO) antibodies (> 34 IU/l) were enrolled as case subjects. Equal number of age (± 1 yr) and sex matched anti-TPO antibody negative controls were selected from the same cohort for paired case-control study. The study subjects (cases) and controls were further divided into two groups as follows: group-1 (children and adolescents ≤ 18 yr), group-2 (adults > 18 yr). Serum samples of cases and controls were analysed for thyroid function test (FT3, FT4, and TSH), anti-TTG and anti-GAD antibodies. The study protocol was approved by the Ethics Committee of the Army Research and Referral Hospital, Delhi Cantt and informed consent was obtained from participants or parents of children.
Thyroid function tests were performed by electrochemiluminiscence assay and normal ranges for FT3, FT4 and TSH were 2.8-7.1 pmol/l, 12.0-22.0 pmol/l, and 0.27-4.20 mIU/l, respectively. Subjects with TSH > 4.5 mIU/l were defined either as subclinical hypothyroidism if FT4 was normal or overt hypothyroidism if FT4 was low. Anti-TPO antibodies were measured by using electrochemiluminiscence kits from Roche (Germany) with normal range from 0.0-34.0 IU/l. Anti-TTG and anti-GAD antibodies were measured by enzyme immunoassay (ELISA) kit supplied by Immunodiagnostic System (USA) as per the manufacturer's protocol. Anti- TTG and anti-GAD antibody levels of >20 and > 1.05 U/ml were considered positive. Intra- and inter-assay coefficients of variation were 3.5 and 8.6 per cent for anti TTG antibodies, and 4.5 and 4.8 per cent for anti-GAD antibody, respectively.
Statistical analysis was carried out using EPI2003 (CDC, Atlanta, USA). Data were presented as mean ± SD or number (%) unless specified. All paired data were analysed by paired t-test. If Barlett's chi-square test for equality of population variances was < 0.05, then Kruskal-Wallis test was applied. All non parametric paired data (case and control) were analysed by McNemar test ( http://www.graphpad.com/quickcalcs/mcnemar1.cfm ).
| Results|| |
Mean age, thyroid function tests and results of anti-TTG and anti-GAD antibody estimation among cases and controls in different age groups are depicted in [Table 1]. Hypothyroidism was present in 40.2 per cent (232) cases when compared to 4.7 per cent (27) in controls (P < 0.001). Overt hypothyroidism was present in 13.1 per cent (n=76) of cases and none in controls. The remaining subjects among hypothyroid group had subclinical hypothyroidism. Overall, FT3 and FT4 levels were significantly lower and TSH levels were significantly higher in cases than in controls. Though FT4 levels were also lower compared to controls in group-1 but was not statistically significance [Table 1].
|Table 1: Thyroid function, anti-TTG and anti-GAD antibodies in groups 1 and 2 patients |
Click here to view
Levels of anti-TTG (6.9%) and anti-GAD (12.5%) antibodies were significantly higher in cases when compared to controls (3.5%, P=0.015; 4.3%, P=0.0001, respectively). However, when the difference in prevalence of TTG antibodies was assessed separately in the two age categories, it failed to attain significance; whereas that for GAD antibodies persisted unchanged [Table 1]. There was no significant difference in anti-TTG and anti-GAD antibody levels between males and females (5.3 vs. 5.1%, P=0.92; and 7.1 vs. 9.7%, P=0.17, respectively). However, anti-TTG and anti-GAD antibody levels increased with increasing titre of anti-TPO antibody [Table 2].
| Discussion|| |
High prevalence of autoimmune thyroiditis with increasing age, female gender and in subjects with hypothyroidism has been well established ,, . The overall presence of anti-TTG antibody was significantly higher among cases than in controls. However, when stratified into children and adults, there was no significant difference. There are limited reports on an increasing prevalence of celiac disease in patients with autoimmune thyroid disorders with rates ranging from 2.0-7.8 per cent ,,,,,, .
High occurrence of anti-TTG antibody (6.4%) was found in children with autoimmune thyroiditis in this study. Limited reports on high occurrence of anti-TTG antibody in children with T1DM  and autoimmune thyroiditis , are available. There are two reports available from Turkey and Italy, where anti-TTG antibodies have been observed in 7.9 and 7.8 per cent children with autoimmune thyroid disease , . Conversely, in patients with celiac disease, anti-TPO antibody and autoimmune thyroiditis have been reported to range from 10.5-14.6 per cent , .
In the present study, anti-TTG antibodies were seen in 3.3 per cent in children and adolescent control group which was similar to that reported earlier (2.5%)  . In contrast, Sari et al did not find anti-TTG positivity in their control group in Turkish children. In a study from northern India anti-TTG antibodies were reported in 10.6 per cent suspected cases of celiac disease through a structured questionnaire in 3-17 yr old children  .
Anti-TTG antibodies were found in 6.3 per cent adult subjects with thyroid autoimmunity in the present study, which is similar to that reported from Turkey  . However, a wide range of markers of celiac disease in subjects with thyroid autoimmunity has been reported [Table 3]. Conversely, high prevalence of anti-thyroid antibodies (13.9-29.7%) among patient with celiac disease has also been reported , . It has been suggested that celiac disease might have a role in the development of thyroid autoimmunity  . The present study showed a positive relation between anti-TTG antibody and anti-TPO antibodies. However, Jiskra et al did not show any significant relation between anti-TPO and anti-TTG-antibodies.
|Table 3: Prevalence of markers of celiac disease in subjects with autoimmune thyroiditis |
Click here to view
Anti-GAD antibody positivity was significantly higher among cases (12.5%) than in controls (4.3%), which persisted even after stratification according to age groups. A low positivity of anti-GAD antibodies (5.1-7.9%) has been reported among non diabetic patients with autoimmune thyroid disease , .
We perhaps for the first time have observed high positivity of anti-GAD antibodies (10.6%) in children with autoimmune thyroiditis.
In our study anti-GAD antibody positivity among adults was significantly higher among cases than in controls (13.8% vs. 5.0% P=0.002). A wide geographic variation in has been reported in anti-GAD positivity in patients with Hashimoto's thyroiditis , . High anti-GAD antibody positivity has been reported among patients with Graves' disease (10-13%)  .
The limitation of the study included absence of histological evaluation of intestinal biopsy to confirm diagnosis of celiac disease and long term follow up of anti-GAD and anti-TTG antibody positive patients to assess the functional significance of these antibodies in the predisposition to celiac disease or type-1 diabetes mellitus.
In conclusion, our study showed high anti-GAD and anti-TTG positivity among subjects with thyroid autoimmunity. It is, therefore, important to have high clinical index of suspicion for these two disorders in patients with autoimmune thyroiditis.
| Acknowledgment|| |
Authors acknowledge the principal and staff of schools and parents of children; Senior Citizen Society who participated in the study and laboratory staff for collection and analysis of samples.
| References|| |
|1.||Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med 2001; 344 : 655-64. |
|2.||Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004; 350 : 2068-79. |
|3.||Bizzaro N. The predictive significance of autoantibodies in organ-specific autoimmune diseases. Clin Rev Allergy Immunol 2008; 34 : 326-31. |
|4.||American Diabetes Association. Standards of medical care in diabetes 2010. Diabetes Care 2010; 33 (Suppl 1) : S11-61. |
|5.||Marwaha RK, Tandon N, Karak AK, Gupta N, Verma K, Kochupillai N. Hashimoto's thyroiditis: countrywide screening of goitrous healthy young girls in postiodization phase in India. J Clin Endocrinol Metab 2000; 85 : 3798-802. |
|6.||Marwaha RK, Tandon N, Gupta N, Karak AK, Verma K, Kochupillai N. Residual goitre in the postiodization phase: iodine status, thiocyanate exposure and autoimmunity. Clin Endocrinol (Oxf) 2003; 59 : 672-81. |
|7.||Meloni A, Mandas C, Jores RD, Congia M. Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr 2009; 155 : 51-5, 55.e1. |
|8.||Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 2010; 123 : 183.e1-9. |
|9.||Chang CL, Jones MK, Kingham JGC. Coeliac disease and autoimmune thyroid disease. Clin Med Res 2007; 5 : 184-92. |
|10.||Akcay MN, Akcay G. The presence of the antigliadin antibodies in autoimmune thyroid diseases. Hepatogastroenterology 2003; 50 (Suppl 2): cclxxix-xxx. |
|11.||Valentino R, Savastano S, Maglio M, Paparo F, Ferrara F, Dorato M, et al. Markers of potential coeliac disease in patients with Hashimoto's thyroiditis. Eur J Endocrinol 2002; 146 : 479-83. |
|12.||Cuoco L, Certo M, Jorizzo RA, De Vitis I, Tursi A, Papa A, et al. Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol 1999; 31 : 283-7. |
|13.||Sari S, Yesilkaya E, Egritas O, Bideci A, Dalgic B. Prevalence of celiac disease in Turkish children with autoimmune thyroiditis. Dig Dis Sci 2009; 54 : 830-2. |
|14.||Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335 : 99-107. |
|15.||Karavanaki K, Kakleas K, Paschali E, Kefalas N, Konstantopoulos I, Petrou V, et al. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm Res 2009; 71 : 201-6. |
|16.||Larizza D, Calcaterra V, De Giacomo C, De Silvestri A, Asti M, Badulli C, et al. Celiac disease in children with autoimmune thyroid disease. J Pediatr 2001; 139 : 738-40. |
|17.||Oderda G, Rapa A, Zavallone A, Strigini L, Bona G. Thyroid autoimmunity in childhood celiac disease. J Pediatr Gastroenterol Nutr 2002; 35 : 704-5. |
|18.||Sood A, Midha V, Sood N, Avasthi G, Sehgal A. Prevalence of celiac disease among school children in Punjab, North India. J Gastroenterol Hepatol 2006; 21 : 1622-5. |
|19.||Guliter S, Yakaryilmaz F, Ozkurt Z, Ersoy R, Ucardag D, Caglayan O, et al. Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population. World J Gastroenterol 2007; 13 : 1599-601. |
|20.||Hakanen M, Luotola K, Salmi J, Laippala P, Kaukinen K, Collin P. Clinical and subclinical autoimmune thyroid disease in adult celiac disease. Dig Dis Sci 2001; 46 : 2631-5. |
|21.||Sategna-Guidetti C, Bruno M, Mazza E, Carlino A, Predebon S, Tagliabue M, et al. Autoimmune thyroid diseases and coeliac disease. Eur J Gastroenterol Hepatol 1998; 10 : 927-31. |
|22.||Duntas LH. Does celiac disease trigger autoimmune thyroiditis? Nat Rev Endocrinol 2009; 5 : 190-1. |
|23.||Jiskra J, Límanová Z, Vaníčková1 Z, Kocna P. IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy. Physiol Res 2003; 52 : 79-88. |
|24.||Collin P, Salmi J, Hällström O, Reunala T, Pasternack A. Autoimmune thyroid disorders and coeliac disease. Eur J Endocrinol 1994; 130 : 137-40. |
|25.||Valentino R, Savastano S, Tommaselli AP, Dorato M, Scarpitta MT, Gigante M, et al. Prevalence of coeliac disease in patients with thyroid autoimmunity. Horm Res 1999; 51 : 124-7. |
|26.||Volta U, Ravaglia G, Granito A, Forti P, Maioli F, Petrolini N, et al. Coeliac disease in patients with autoimmune thyroiditis. Digestion 2001; 64 : 61-5. |
|27.||Hadithi M, de Boer H, Meijer JW, Willekens F, Kerckhaert JA, Heijmans R, et al. Coeliac disease in Dutch patients with Hashimoto's thyroiditis and vice versa. World J Gastroenterol 2007; 13 : 1715-22. |
|28.||Kawasaki E, Abiru N, Yano M, Uotani S, Matsumoto K, Matsuo H, et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995; 8 : 633-43. |
|29.||Aksoy DY, Yürekli BP, Yildiz BO, Gedik O. Prevalence of glutamic acid decarboxylase antibody positivity and its association with insulin secretion and sensitivity in autoimmune thyroid disease: a pilot study. Exp Clin Endocrinol Diabetes 2006; 114 : 412-6. |
|30.||Maugendre D, Vérité F, Guilhem I, Genetet B, Allannic H, Delamaire M. Anti-pancreatic autoimmunity and Graves' disease: study of a cohort of 600 Caucasian patients. Eur J Endocrinol 1997; 137 : 503-10. |
[Table 1], [Table 2], [Table 3]